EyePoint (EYPT) Other Working Capital Changes (2010 - 2018)
EyePoint (EYPT) reported Other Working Capital Changes of -$6000.0 for Q1 2026, up 99.97% on a YoY basis from -$3000.4 in Q1 2025, and up 14.29% sequentially from -$7000.0 in Q4 2025.
EyePoint (EYPT) Other Working Capital Changes (2010 - 2018) Analysis & Trends
EyePoint (EYPT) has 9 years of Other Working Capital Changes data on file, last reported at -$6000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 99.97% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at $23.5 million (up 151.76% YoY), and the FY2025 full-year result was -$33000.0, up 99.89% from the prior year.
- Other Working Capital Changes improved to -$6000.0 in Q1 2026, from -$7000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $495000.0 in Q4 2017 to a low of -$1.1 million in Q1 2014.
- A 5-year average of -$93222.2 and a median of -$9500.0 in 2015 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 36260.61% in 2023, while the deepest fall reached 6191.22% in 2023.
- Tracing EYPT's Other Working Capital Changes over 5 years: stood at -$205000.0 in 2022, then slumped by 6191.22% to -$12.9 million in 2023, then sank by 137.62% to -$30.6 million in 2024, then jumped by 99.98% to -$7000.0 in 2025, then advanced by 14.29% to -$6000.0 in 2026.
- Business Quant data shows EYPT's Other Working Capital Changes at -$6000.0 in Q1 2026, -$7000.0 in Q4 2025, and -$8000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | -16,000.00 |
| Jun 30, 2018 | -16,000.00 |
| Jun 30, 2018 | -16,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Mar 31, 2018 | -265,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Dec 31, 2017 | 495,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Sep 30, 2017 | -40,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Jun 30, 2017 | -10,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Mar 31, 2017 | 120,000.00 |
| Dec 31, 2016 | -3,000.00 |
| Dec 31, 2016 | -3,000.00 |